TMCnet News
Fresenius Kabi - U.S. PROPOFOL MARKET SHARE UPDATE(ENP Newswire Via Acquire Media NewsEdge) ENP Newswire - 20 August 2014 Release date- 19082014 - According to IMS, Fresenius Kabi's market share for Propofol and its equivalent, Diprivan, remained unchanged at 74% in June. Since March, IMS data on our competition has included direct sales to hospitals. Fresenius Kabi does not report direct sales; our market share is therefore not fully reflected in IMS data. (c) 2014 Electronic News Publishing - |